Faraz Zarghami

406 total citations
7 papers, 349 citations indexed

About

Faraz Zarghami is a scholar working on Molecular Biology, Molecular Medicine and Pharmacology. According to data from OpenAlex, Faraz Zarghami has authored 7 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Molecular Medicine and 2 papers in Pharmacology. Recurrent topics in Faraz Zarghami's work include Curcumin's Biomedical Applications (4 papers), RNA Interference and Gene Delivery (2 papers) and Telomeres, Telomerase, and Senescence (2 papers). Faraz Zarghami is often cited by papers focused on Curcumin's Biomedical Applications (4 papers), RNA Interference and Gene Delivery (2 papers) and Telomeres, Telomerase, and Senescence (2 papers). Faraz Zarghami collaborates with scholars based in Iran, Australia and France. Faraz Zarghami's co-authors include Nosratollah Zarghami, Younes Pilehvar‐Soltanahmadi, Abolfazl Akbarzadeh, Farideh Mohammadian, Shahriar Alipour, Kazem Nejati‐Koshki, Mohammad Rahmati Yamchi, Sedigheh Fekri Aval, Hadi Sadeghzadeh and Alireza Nikanfar and has published in prestigious journals such as International Journal of Pharmaceutics, Biosensors and Bioelectronics and Artificial Cells Nanomedicine and Biotechnology.

In The Last Decade

Faraz Zarghami

7 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Faraz Zarghami Iran 6 184 90 67 65 44 7 349
Jui-Yu Wu Taiwan 10 117 0.6× 108 1.2× 33 0.5× 86 1.3× 28 0.6× 11 436
Mahdie Hemati Iran 11 167 0.9× 118 1.3× 35 0.5× 90 1.4× 56 1.3× 25 414
Wanshan Ma China 12 246 1.3× 41 0.5× 48 0.7× 92 1.4× 69 1.6× 34 452
Jianlin Long China 6 167 0.9× 183 2.0× 185 2.8× 78 1.2× 46 1.0× 14 451
Anis Askarizadeh Iran 10 119 0.6× 137 1.5× 38 0.6× 96 1.5× 22 0.5× 17 322
Golnaz Kamalinia Iran 11 213 1.2× 232 2.6× 42 0.6× 122 1.9× 18 0.4× 17 573
Mohammad Rahmati Yamchi Iran 6 219 1.2× 263 2.9× 82 1.2× 177 2.7× 43 1.0× 7 635
Cristina Ana Constantinescu Romania 13 162 0.9× 77 0.9× 26 0.4× 55 0.8× 18 0.4× 15 392
Kave Moloudi South Africa 12 101 0.5× 118 1.3× 44 0.7× 169 2.6× 38 0.9× 21 384

Countries citing papers authored by Faraz Zarghami

Since Specialization
Citations

This map shows the geographic impact of Faraz Zarghami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faraz Zarghami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faraz Zarghami more than expected).

Fields of papers citing papers by Faraz Zarghami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faraz Zarghami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faraz Zarghami. The network helps show where Faraz Zarghami may publish in the future.

Co-authorship network of co-authors of Faraz Zarghami

This figure shows the co-authorship network connecting the top 25 collaborators of Faraz Zarghami. A scholar is included among the top collaborators of Faraz Zarghami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faraz Zarghami. Faraz Zarghami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Pilehvar‐Soltanahmadi, Younes, et al.. (2017). Silibinin-loaded magnetic nanoparticles inhibit hTERT gene expression and proliferation of lung cancer cells. Artificial Cells Nanomedicine and Biotechnology. 45(8). 1649–1656. 70 indexed citations
2.
Alizadeh‐Ghodsi, Mohammadreza, Hamed Hamishehkar, Abolfazl Akbarzadeh, et al.. (2016). Design and development of PCR-free highly sensitive electrochemical assay for detection of telomerase activity using Nano-based (liposomal) signal amplification platform. Biosensors and Bioelectronics. 80. 426–432. 45 indexed citations
3.
Mohammadian, Farideh, Alireza Abhari, Hassan Dariushnejad, et al.. (2016). Upregulation of Mir-34a in AGS Gastric Cancer Cells by a PLGA-PEG-PLGA Chrysin Nano Formulation. Asian Pacific Journal of Cancer Prevention. 16(18). 8259–8263. 59 indexed citations
4.
Mohammadian, Farideh, Younes Pilehvar‐Soltanahmadi, Faraz Zarghami, Abolfazl Akbarzadeh, & Nosratollah Zarghami. (2016). Upregulation of miR-9 and Let-7a by nanoencapsulated chrysin in gastric cancer cells. Artificial Cells Nanomedicine and Biotechnology. 45(6). 1201–1206. 60 indexed citations
5.
Montazeri, Maryam, Majid Sadeghizadeh, Younes Pilehvar‐Soltanahmadi, et al.. (2016). Dendrosomal curcumin nanoformulation modulate apoptosis-related genes and protein expression in hepatocarcinoma cell lines. International Journal of Pharmaceutics. 509(1-2). 244–254. 60 indexed citations
6.
Zarghami, Nosratollah, et al.. (2015). Synergistic Effects of Chrysin-Curcumin Loaded in PLGA-PEG Nanoparticles on Inhibiting Breast Cancer Cell Line Growth. 2(12). 1 indexed citations
7.
Aval, Sedigheh Fekri, Abolfazl Akbarzadeh, Mohammad Rahmati Yamchi, et al.. (2014). Gene silencing effect of SiRNA-magnetic modified with biodegradable copolymer nanoparticles on hTERT gene expression in lung cancer cell line. Artificial Cells Nanomedicine and Biotechnology. 44(1). 188–193. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026